Eric Ostertag

Chairman
Poseida Therapeutics
San Diego, California, United States

Presentation(s):

• OC 30.5 - Expression and Activity of Human Factor VIII (hFVIII) Following Single and Repeat Administration of an Integrating Non-viral Gene Therapy in Multiple Mouse Models of Severe Hemophilia A

  Monday, June 26, 2023
  11:45 – 12:00 ET